Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission in which antibodies are directed against voltage-gated calcium channels (VGCCs). We studied the action of LEMS immunoglobulin G (IgG) on cloned human VGCCs stably transfected into human embryonic kidney...
Egile Nagusiak: | Lang, B, Pinto, A, Giovannini, F, Newsom-Davis, J, Vincent, A |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2003
|
Antzeko izenburuak
-
Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
nork: Bain, P, et al.
Argitaratua: (1996) -
Autoantibodies in the Lambert-Eaton myasthenic syndrome (LEMS) and amyotrophic lateral sclerosis (ALS)
nork: Lang, B
Argitaratua: (2007) -
Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)
nork: Lang, B, et al.
Argitaratua: (2013) -
Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
nork: Motomura, M, et al.
Argitaratua: (1997) -
Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
nork: Maddison, P, et al.
Argitaratua: (2001)